No Data
No Data
Even With A 26% Surge, Cautious Investors Are Not Rewarding Changchun BCHT Biotechnology Co.'s (SHSE:688276) Performance Completely
Is Weakness In Changchun BCHT Biotechnology Co. (SHSE:688276) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects?
Baik Biological (688276.SH): Shareholder Wei Xuening intends to reduce his shareholding by no more than 0.5 million shares.
On September 13th, Gelonghui announced that the company received a notice from shareholder Mr. Wei Xuening regarding the shareholding reduction plan on September 13, 2024. Mr. Wei Xuening plans to reduce his total holding of the company's shares by no more than 0.5 million shares through centralized bidding in accordance with market conditions. The planned reduction in the number of shares represents a total of no more than 0.1209% of the company's total share capital, and the reduction period is within 3 months after 15 trading days from the disclosure of this announcement.
Downgrade: Here's How Analysts See Changchun BCHT Biotechnology Co. (SHSE:688276) Performing In The Near Term
Changchun BCHT Biotechnology H1 Profit Up 24%, Operating Income Rises 11%
Changchun Baike Biological Technology Co., Ltd.'s 2024 bi-annual report.
No Data
No Data